Dengue serotype immune-interactions and their consequences for vaccine impact predictions.
Dengue is one of the most important and wide-spread viral infections affecting human populations. The last few decades have seen a dramatic increase in the global burden of dengue, with the virus now being endemic or near-endemic in over 100 countries world-wide. A recombinant tetravalent vaccine candidate (CYD-TDV) has recently completed Phase III clinical efficacy trials in South East Asia and Latin America and has been licensed for use in several countries. The trial results showed moderate-to-high efficacies in protection against clinical symptoms and hospitalisation but with so far unknown effects on transmission and infections per se. Model-based predictions about the vaccine's short- or long-term impact on the burden of dengue are therefore subject to a considerable degree of uncertainty. Furthermore, different immune interactions between dengue's serotypes have frequently been evoked by modelling studies to underlie dengue's oscillatory dynamics in disease incidence and serotype prevalence. Here we show how model assumptions regarding immune interactions in the form of antibody-dependent enhancement, temporary cross-immunity and the number of infections required to develop full immunity can significantly affect the predicted outcome of a dengue vaccination campaign. Our results thus re-emphasise the important gap in our current knowledge concerning the effects of previous exposure on subsequent dengue infections and further suggest that intervention impact studies should be critically evaluated by their underlying assumptions about serotype immune-interactions.
Department of Zoology, University of Oxford, Oxford OX1 3PS, UK.
José
J
Lourenço
Centre for Mathematics and the Environment, University of Exeter, Penryn Campus, Penryn TR10 9EZ, UK. Electronic address: m.recker@exeter.ac.uk.
Mario
M
Recker
D003715:Dengue / Q000276:immunology / Q000517:prevention & control*; D053059:Dengue Vaccines / Q000276:immunology*; D006801:Humans; D017589:Immunization Programs; D007843:Latin America; D065288:Serogroup; D014613:Vaccines, Attenuated / Q000276:immunology*
D053059:Dengue Vaccines; D014613:Vaccines, Attenuated
Am J Trop Med Hyg. 1988 Jan;38(1):172-80
3341519
Vaccine. 2015 Jun 26;33(29):3293-8
25989449
Vaccine. 2014 Jan 16;32(4):514-20
24269318
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14234-9
16966609
N Engl J Med. 2015 Sep 24;373(13):1195-206
26214039
Trans R Soc Trop Med Hyg. 2010 Sep;104(9):592-600
20630553
Lancet. 2007 Nov 10;370(9599):1644-52
17993365
PLoS Comput Biol. 2013 Oct;9(10):e1003308
24204241
Vaccine. 2013 Aug 20;31(37):3957-61
23791696
Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):1939-44
24385585
PLoS Negl Trop Dis. 2014 Aug 21;8(8):e3083
25144749
Lancet. 2012 Nov 3;380(9853):1559-67
22975340
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2238-43
18250338
Expert Rev Vaccines. 2016;15(4):437-41
26775653
Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15259-64
16217017
Am J Trop Med Hyg. 2003 May;68(5):539-44
12812340
J Theor Biol. 2014 Feb 7;342:15-22
24161462
Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):790-4
9892712
J Infect Dis. 2000 Jan;181(1):2-9
10608744
N Engl J Med. 2015 Jan 8;372(2):113-23
25365753
Am J Trop Med Hyg. 2007 Nov;77(5):910-3
17984352
Annu Rev Microbiol. 2008;62:71-92
18429680
PLoS Negl Trop Dis. 2012;6(10):e1876
23145197
PLoS Negl Trop Dis. 2010 Nov 23;4(11):e894
21124880
Am J Trop Med Hyg. 1987 Jan;36(1):143-52
3812879
PLoS Negl Trop Dis. 2012;6(3):e1450
22479655
Epidemiol Infect. 2014 Jun;142(6):1245-58
23925059
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11802-7
16868086
PLoS Negl Trop Dis. 2015 Jun 11;9(6):e0003749
26065421
Proc Biol Sci. 2009 Jul 22;276(1667):2541-8
19369266
J R Soc Interface. 2013 Jul 03;10(86):20130414
23825116
PLoS Negl Trop Dis. 2011 Mar 01;5(3):e975
21390158
Bull World Health Organ. 1981;59(4):623-30
6976230
Am J Trop Med Hyg. 1952 Jan;1(1):30-50
14903434
Vaccine. 2011 Aug 11;29(35):5860-8
21699949
Am J Trop Med Hyg. 2010 Apr;82(4):731-9
20348527
Am J Trop Med Hyg. 2000 Jan;62(1):11-8
10761719
J Med Entomol. 1995 Jan;32(1):27-33
7869339
Am J Trop Med Hyg. 2014 Aug;91(2):235-9
24891464
Lancet. 2014 Oct 11;384(9951):1358-65
25018116
PLoS One. 2010 Aug 23;5(8):e12347
20808806
PLoS One. 2012;7(12):e51244
23251466
Trends Microbiol. 2014 Mar;22(3):138-46
24468533
PLoS One. 2012;7(11):e49085
23139836
Philos Trans R Soc Lond B Biol Sci. 1999 Apr 29;354(1384):757-68
10365401
Vaccine. 2015 Jul 17;33(31):3746-51
26051515
N Engl J Med. 2012 Apr 12;366(15):1423-32
22494122
Am J Trop Med Hyg. 1986 Nov;35(6):1263-79
3789275